

#144 Cell Danger Response- Clinical Implications
Register below to watch Dr. Anderson record the LIVE webinar on Tuesday November 17th, 2026 @ 5:30 PM PST
Abstract:
The cell danger response (CDR) is a universal response to environmental threat or injury. Once triggered, healing cannot be completed until the choreographed stages of the CDR are returned to an updated state of readiness. Although the CDR is a cellular response, it has the power to change human thought and behavior, child development, physical fitness and resilience, fertility, and the susceptibility of entire populations to disease. Mitochondria regulate the CDR by monitoring and responding to the physical, chemical, and microbial conditions within and around the cell. In this way, mitochondria connect cellular health to environmental health. Over 7,000 chemicals are now made or imported to the US for industrial, agricultural, and personal care use in amounts ranging from 25,000 to over 1 million pounds each year, and plastic waste now exceeds 83 billion pounds/year. This chemical load creates a rising tide of manmade pollutants in the oceans, air, water, and food chain. Fewer than 5% of these chemicals have been tested for developmental toxicity. In the 1980s, 5–10% of children lived with a chronic illness. As of 2018, 40% of children, 50% of teens, 60% of adults under age 65, and 90% of adults over 65 live with a chronic illness. Several studies now report the presence of dozens to hundreds of manmade chemicals and pollutants in placenta, umbilical cord blood, and newborn blood spots. New methods in metabolomics and exposomics allow scientists to measure thousands of chemicals in blood, air, water, soil, and the food chain. **Adapted from Robert K. Naviaux. Professor of Genetics, Departments ofMedicine, Pediatrics, and Pathology, University of California, San Diego School of Medicine
Learning Objectives:
- Discuss the concept of the Cell Danger Response (CDR)
- Describe the phases of mitochondrial biogenesis
- Discuss the loci of dysfunction in the CDR
CME Effective Date:
Live Event: November 17th, 2026
CME Expiration Date:
Live Event: December 17th, 2026
Educational Credits:
1.5 AMA/PRA Category 1 CME Credit™
1.5 Nursing Contact Hours (0.5 Pharmacological)
Target Audience:
This program is intended for: Physicians (MD, ND, Other), Nurses, Nurse Practitioners, and Other Healthcare professionals
Conflict of Interest Disclosure Policy
Identify, Mitigate, and Disclose Relevant Financial Relationships
Many healthcare professionals have financial relationships with ineligible companies. These relationships must not be allowed to influence accredited continuing education. The Foundation for Care Management (FCM) as the accredited provider is responsible for identifying relevant financial relationships between individuals in control of educational content and ineligible companies and managing these to ensure they do not introduce commercial bias into the education. Financial relationships are defined as relevant if the educational content is related to the business lines or products of the ineligible company. As an accredited provider FCM collects information from planners, faculty and others in control of educational content and conducts an extensive review process. Financial relationships are identified, reviewed and mitigated. In some cases. speakers and committee members may be excluded. All relevant financial relationships are disclosed to the learner below as required by the ACCME.
Disclosures:
Planner/Presenter: Dr. Paul Anderson discloses the following: NFH – Vitazan; Science Advisory Board Member, MD Lifespan; Science Advisory Board Member, Priority One; Formulation Advisor.
Reviewers: Kenneth Meyer discloses no financial relationships with any ineligible companies.
No individual(s) at the Foundation for Care Management (FCM) who had control over the planning or content of this activity has relevant financial relationships with ineligible companies.
To the degree possible all identifying “commercial” detail has been left out of the slides.
Any proprietary products mentioned in the audio Q&A are only due to direct clarifying questions by the attendees, and no product, lab or supplier has any financial connection to the presenter.
Accreditation Statement:
Washington State ND’s: This CME is co-accredited by WANP which allows WA State Category-1 CME Credit for WA Licensed ND’s

In support of improving patient care, this activity has been planned and implemented by the Foundation for Care Management (FCM) and P S Anderson LLC. FCM is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
This program is approved for 1.5 AMA Category 1 CreditsTM
This program is approved for 1.5 Nursing Contact Hours (0.5 Pharmacological)
Healthcare providers should only claim credit commensurate with the extent of their participation in this activity.
